Pharmacological interventions for promoting smoking cessation during pregnancy

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Coleman, Tim ^a   Chamberlain, Catherine ^b   Davey, Mary Ann ^c   Cooper, Sue E ^a   Leonardi Bee, Jo ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; VARENICLINE; NICOTINIC AGENT;

BIRTH WEIGHT; CESAREAN SECTION; CHILD DEVELOPMENT; COGNITIVE BEHAVIORAL THERAPY; DRUG EFFICACY; DRUG SAFETY; ELECTRONIC CIGARETTE; HEADACHE; HEALTH PROMOTION; HUMAN; NAUSEA; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; POSTNATAL CARE; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SKIN IRRITATION; SMOKING CESSATION; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; THERAPY EFFECT; FEMALE; META ANALYSIS; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BUPROPION; FEMALE; HUMANS; NICOTINIC AGONISTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; VARENICLINE;

EID: 84960180838     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010078.pub2     Document Type: Review

References (156)

1. Berlin I. Study of Nicotine Patch in Pregnancy (SNIPP). ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT00507975) (accessed 2008).
2. Berlin I, Grange G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:1622.
3. Bowker KA, Lewis S, Coleman T, Vaz LR, Cooper S. Comparison of cotinine levels in pregnant women whilst smoking and when using nicotine replacement therapy. Nicotine & Tobacco Research 2014;16(6):895-8.
4. Coleman T, Cooper S, Thornton JG, Grainge MJ, Watts K, Britton J, et al. Smoking, Nicotine, and Pregnancy (SNAP) Trial Team. A randomized trial of nicotine-replacement therapy patches in pregnancy. New England Journal of Medicine 2012;366:808-18.
5. Coleman T, Thornton J, Britton J, Lewis S, Watts K, Coughtrie MW, et al. Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research 2007;3(7):2.
6. Cooper S, Lewis S, Thornton JG, Marlow N, Watts K, Britton J, et al. Smoking, Nicotine and Pregnancy Trial Team. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment 2014;18(54):1-128.
7. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Smoking, Nicotine and Pregnancy (SNAP) Trial Team. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet. Respiratory Medicine 2014;2(9):728-37.
8. Essex HN, Parrott S, Wu Q, Li J, Cooper S, Coleman T. Cost-effectiveness of nicotine patches for smoking cessation in pregnancy: A placebo randomised controlled trial (SNAP). Nicotine & Tobacco Research 2014;17(6):636-42.
9. Grainge M, Coleman T, Cooper S, Thornton J, Watts K, Britton J, et al. Double-blind, placebo-controlled randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine 2012;39 Suppl:172.
10. Thornton JG, Coleman T, Britton J, Cooper S, Watts K, Lewis S, et al. The smoking, nicotine and pregnancy (SNAP) trial: Main results. Archives of Disease in Childhood: Fetal and Neonatal Edition 2011;96(Suppl 1):Fa109.
11. El-Mohandes AAE, Windsor R, Tan S, Perry D, Gantz M, Kiely M. A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers. Maternal & Child Health Journal 2013;17(5):897-906.
12. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Effectiveness of nicotine replacement therapy in reducing the risk of nicotine exposure in pregnant minority smokers. Clinicaltrials.gov (http://clinicaltrials.gov/ct2/show/NCT00341432?term=NCT00341432&rank=1) (accessed 2006).
13. Atkinson E, Hotham L, Baghurst P. Nicotine replacement therapy as an adjunct to smoking cessation counselling in pregnancy: a randomised study to evaluate efficacy in an antenatal clinic setting. Australian and New Zealand Journal of Obstetrics and Gynaecology 2003;43(2):177-87. Refereed abstracts of original presentations at the 2nd International Meeting of the International Society of Perinatal Obstetricians; 10-13 November 2002; Adelaide.
14. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addictive Behaviors 2006;31(4):641-8.
15. Hotham ED, Gilbert AL, Atkinson ER. Case studies of three pregnant smokers and their use of nicotine replacement therapy. Midwifery 2005;21(3):224-32.
16. Kapur B, Hackman R, Selby P, Klein J, Koren G. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Current Therapeutic Research - Clinical and Experimental 2001;62(4):274-8.
17. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Feinn R, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstetrics & Gynecology 2008;112(4):859-67.
18. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Kranzler HR. Nicotine gum for pregnant smokers: a randomized controlled trial. Proceedings of the 70th Annual Scientific Meeting of the College on Problems on Drug Dependence; 2008 June 14-19; San Juan, Puerto Rico. 2008:143.
19. Fish LJ, Peterson BL, Namenek-Brouwer RJ, Lyna P, Oncken CA, Swamy GK, et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine and Tobacco Research 2009;11(5):514-8.
20. Pollak KI, Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. American Journal of Preventive Medicine 2007;33(4):297-305.
21. Pollak KI, Oncken CA, Lipkus IM, Peterson BL, Swamy GK, Pletsch PK, et al. Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine and Tobacco Research 2006;8(4):547-54.
22. Pollak KI, Oncken CA, Lipkus IM, Peterson BL, Swamy GK, Pletsch PK, et al. Effectiveness of adding nicotine replacement therapy to cognitive behavioural therapy for smoking cessation in pregnant smokers: the Baby Steps Trial. Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 Feb 21-24; Austin, Texas. 2007:25, Abstract no: PA6-3.
23. Swamy GK, Roelands JJ, Peterson BL, Fish LJ, Oncken CA, Pletsch PK, et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics and Gynecology 2009;201:354.e1-354.e7.
24. Stotts A. Double blind, placebo-controlled pilot study of Bupropion to promote smoking cessation during pregnancy. ClinicalTrials.gov (accessed 21 May 2013) 2011.
25. Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, et al. Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions. American Journal of Perinatology 2015;32(4):351-6.
26. Wisborg K. Nicotine patches to pregnant smokers - a randomised study. 1st International Conference of the Society for Research on Nicotine and Tobacco; 1998 August 22-23; Copenhagen, Denmark. 1998.
27. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstetrics & Gynecology 2000;96(6):967-71.
28. Eades SJ, Sanson-Fisher RW, Wenitong M, Panaretto K, D'Este C, Gilligan C, et al. An intensive smoking intervention for pregnant Aboriginal and Torres Strait Islander women: a randomised controlled trial. Medical Journal of Australia 2012;197(1):42-6.
29. Gilligan C. A pilot randomised controlled trial to test the effectiveness of an intervention to help Aboriginal and Torres Strait Islander women to quit smoking during pregnancy: study design and preliminary results [thesis]. Newcastle, Australia: University of Newcastle 2008.
30. Hegaard HK, Kjaergaard H, Moller LF, Wachmann H, Ottesen B. Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2003;82(9):813-9.
31. Oncken C, Campbell W, Chan G, Hatsukami D, Kranzler HR. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. Journal of Maternal-Fetal and Neonatal Medicine 2009;22(9):751-8.
32. Hankins GDV. Bupropion for smoking cessation during pregnancy. ClinicalTrial.gov (http://clinicaltrials.gov) (accessed March 2014) 2011.
33. Koren G. Study of nicotine replacement therapy in pregnancy. ClinicalTrials.gov (http://clinicaltrials.gov) (accessed 4 January 2009).
34. Kranzler HR. Placebo-controlled trial of bupropion for smoking cessation in pregnant women. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 2 September 2014) 2014.
35. Oncken C. Pilot study of nicotine replacement for smoking cessation during pregnancy. http://clinicaltrials.gov/ct2/show/NCT00888979 (accessed 3 February 2012) 2009.
36. Oncken C. Nicotine replacement for smoking cessation during pregnancy. ClinicalTrials.gov (accessed May 2014) 2012.
37. ASH Briefing on electronic cigarettes. Action on Smoking and Health (http://ash.org.uk/information/facts-and-stats/ash-briefings) [accessed on 18 December 2014] 2014.
38. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. American Journal of Preventive Medicine 2013;44(3):207-15.
39. Al-Sahab B, Saqib M, Hauser G, Tamim H. Prevalence of smoking during pregnancy and associated risk factors among Canadian women: a national survey. BMC Pregnancy and Childbirth 2010;10:24; doi:10.1186/1471-2393-10-24.
40. Andreski P, Breslau N. Maternal smoking among blacks and whites. Social Science and Medicine 1995;41(2):227-33.
41. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, et al. Bupropion: a review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry 1995;56(9):395-401.
42. Auf R. Electronic cigarettes and smoking cessation: a quandary?. Lancet 2014;383(9915):408.
43. Aveyard R, West R. Managing smoking cessation. BMJ 2007;335:37-41.
44. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reproductive Toxicology 2012;34(4):529-37.
45. Baric L, MacArthur C. Health norms in pregnancy. British Journal of Preventive and Social Medicine 1977;31(1):30-8.
46. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL, et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tobacco Control 2000;9 Suppl 3(0964-4563):III91-4.
47. Benowitz NL. Emerging nicotine delivery products. Implications for public health. Annals of the American Thoracic Society 2014;11(2):231-5.
48. Bialous SA, Sarma L. Electronic cigarettes and smoking cessation: a quandary?. Lancet 2014;383(9915):407-8.
49. Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addictive Behaviors 2005;30(6):1195-208.
50. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014;109(9):1531-40.
51. Brown CJ, Cheng JM. Electronic cigarettes: product characterisation and design considerations. Tobacco Control 2014;23(Suppl 2):ii4-ii10.
52. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicological Sciences 2010;116(2):364-74.
53. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382(9905):1629-37.
54. Bush J, White M, Kai J, Rankin J, Bhopal R. Understanding influences on smoking in Bangladeshi and Pakistani adults: community based, qualitative study. BMJ 2003;326:962.
55. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD006103.pub6]
56. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS ONE 2013;8(6):e66317.
57. Centers for Disease Control and Prevention. Women and smoking: a report of the Surgeon General (executive summary). Morbidity and Mortality Weekly Report 51 (No. RR-12) 2002, issue Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5112a4.htm:Accessed 9/8/2015.
58. Chamberlain C, O'Mara-Eves A, Oliver S, Caird JR, Perlen SM, Eades SJ, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD001055.pub4]
59. Chan A, Keane RJ, Robinson JS. The contribution of maternal smoking to preterm birth, small for gestational age and low birth weight among aboriginal and non-aboriginal births in South Australia. Medical Journal of Australia 2001;174(8):389-93.
60. Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. Journal of Addictive Diseases 2005;24(2):19-23.
61. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine and Tobacco Research 2004;6(S2):S125-S140.
62. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". American Journal of Public Health 2010;100(12):2340-2.
63. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry 2005;48(10):3474-7.
64. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011;106 (1):52-61.
65. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Efficacy of nicotine replacement therapy in pregnancy. BJOG: an international journal of obstetrics and gynaecology 2013;120(3):373-4.
66. Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM, et al. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 1994;11(2):133-41.
67. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respiratory Medicine 2014;2(9):728-37.
68. Crawford JT, Tolosa JE, Goldenberg RL. Smoking cessation in pregnancy: why, how, and what next. Clinical Obstetrics and Gynecology 2008;51(2):419-35.
69. Crittenden, KS, Manfredi C, Cho YI, Dolecek TA. Smoking cessation processes in low-SES women: the impact of time-varying pregnancy status, healthcare messages, stress and health concerns. Addictive Behaviours 2007;32(7):1347-66.
70. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Safety 2001;24(4):277-322.
71. Dixon L, Aimer P, Fletcher L, Guilliland K, Hendry C. Smoke free outcomes with midwife lead maternity carers: an analysis of smoking during pregnancy from the New Zealand College of Midwives Midwifery database 2004-2007. New Zealand College of Midwives Journal 2009;40:13-9.
72. Doyle C, Patterson S, Scott J. Electronic cigarettes and smoking cessation: a quandary?. Lancet 2014;383(9915):408.
73. Drummond MB, Upson D. Electronic cigarettes. Potential harms and benefits. Annals of the American Thoracic Society 2014;11(2):236-42.
74. Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacology & Therapeutics 2009;122(2):125-39.
75. Ebert LM, Fahy K. Why do women continue to smoke in pregnancy?. Women and Birth 2007;20(4):161-8.
76. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106(11):2017-28.
77. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety 2014;5(2):67-86.
78. Fish LJ, Peterson BL, Namenek Brouwer RJ, Lyna P, Oncken CA, Swamy GK, et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine & Tobacco Research 2009;11(5):514-8.
79. Franck C, Budlovsky T, Windle SB, Filion KB, Eisenberg MJ. Electronic cigarettes in North America: history, use, and implications for smoking cessation. Circulation 2014;129(19):1945-52.
80. Frost FJ, Cawthorn ML, Tollestrup K, Kenny FW, Schrager LS, Nordlund DJ. Smoking prevalence during pregnancy for women who are and women who are not Medicaid-funded. American Journal of Preventive Medicine 1994;10(2):91-6.
81. Gaither KH, Brunner-Huber LR, Thompson ME, Huet-Hudson YM. Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes. Maternal and Child Health Journal 2009;13(4):497-504.
82. Gilligan C, Sanson-Fisher R, Eades S, D'Este C. Antenatal smoking in vulnerable population groups: an area of need. Journal of Obstetrics and Gynaecology 2007;27(7):664-71.
83. Giovino GA. The tobacco epidemic in the United States. American Journal of Preventive Medicine 2007;33(6 Suppl):S318-S326.
84. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in-utero and early life conditions on adult health and disease. New England Journal of Medicine 2008;359(1):61-73.
85. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control 2014;23(2):133-9.
86. Graham H. Smoking in pregnancy: the attitudes of pregnant mothers. Social Science and Medicine 1976;10(7-8):399-405.
87. Graham H. Smoking prevalence among women in the European community 1950-1990. Social Science and Medicine 1996;43(2):243-54.
88. Graham H, Hawkins SS, Law C. Lifecourse influences on women's smoking before, during and after pregnancy. Social Science and Medicine 2010;70(4):582-7.
89. Grana R, Benowitz N, Glantz SA. E-Cigarettes: a scientific review. Circulation 2014;129(19):1972-86.
90. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Internal Medicine 2014;174(5):812-3.
91. Green NS, Damus K, Simpson JL, Iams J, Reece EA, Hobel CJ, et al. Research agenda for preterm birth: recommendations from the March of the Dimes. American Journal of Obstetrics and Gynecology 2005;193(3 Pt 1):626-35.
92. Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. American Journal of Obstetrics and Gynecology 2005;192(6):1856-63.
93. Harrell PT, Simmons VN, Correa JB, Padhya TA, Brandon TH. Electronic nicotine delivery systems (“e-cigarettes”): review of safety and smoking cessation efficacy. Otolaryngology -- Head and Neck Surgery 2014;151(3):381-93.
94. Herrmann M, King K, Weitzman M. Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Current Opinion in Pediatrics 2008;20(2):184-90.
95. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
96. Hitchman SC, McNeill A, Brose LS. Electronic cigarettes: time for an accurate and evidence-based debate. Addiction 2014;109(6):867-8.
97. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4]
98. Hunt J. Trying to make a difference: improving pregnancy outcomes, care and services for Australian indigenous women [thesis]. Victoria: LaTrobe University, 2003.
99. Kaplan SD, Lanier AP, Merritt RK, Siegel PZ. Prevalence of tobacco use among Alaska natives: a review. Preventive Medicine 1997;26(4):460-5.
100. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987;65(5):663-737.
101. Lanting CI, van Wouwe JP, van den Burg I, Segaar D, van der Pal-de Bruin KM. Smoking during pregnancy: trends between 2001 and 2010 [Roken tijdens de zwangerschap: trends in de periode 2001-2010]. Nederlands Tijdschrift Voor Geneeskunde 2012;156(46):A5092.
102. Maritz GS. Are nicotine replacement therapy, varencline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. Therapeutic Advances in Respiratory Disease 2009;3(4):193-210.
103. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Education Research 2003;18(2):156-70.
104. McCowan LME, Dekker GA, Chan E, Stewart A, Chappell LC, Hunter M, et al. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. BMJ 2009;338:b1081.
105. McNeill A, Etter J-F, Farsalinos K, Hajek P, le Houezec J, McRobbie H. A critique of a World Health Organization-commissioned report and associated paper on electronic cigarettes. Addiction 2014;109(12):2128-34.
106. Murin S, Rafii R, Bilello K. Smoking and smoking cessation in pregnancy. Clinics in Chest Medicine 2011;32(1):75-91.
107. Myung SK, Ju W, Jung HS, Park CH, Oh SW, Seo H, et al. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. BJOG: an international journal of obstetrics and gynaecology 2012;119(9):1029-39.
108. National Institute for Clinical Excellence. Guidance on the use of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation. Technology Appraisal Guidance No.39. London: National Institute for Clinical Excellence, 2002.
109. Oncken CA, Kranzler HR. What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?. Nicotine and Tobacco Research 2009;11(11):1265-73.
110. Oncken CA, Dietz PA, Tong VT, Belizan JM, Tolosa JE, Berghella V, et al. Prenatal tobacco prevention and cessation interventions for women in low- and middle- income countries. Acta Obstetricia et Gynecologica Scandinavica 2010;89(4):442-53.
111. Orr MS. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tobacco Control 2014;23(Suppl 2):ii18-22.
112. Osadchy A, Kazmin A, Koren G. Nicotine replacement therapy during pregnancy: recommended or not recommended?. Journal of Obstetrics and Gynaecology Canada 2009;31(8):744-7.
113. Pickett KE, Wilkinson RG, Wakschlag LS. The psychosocial context of pregnancy smoking and quitting in the Millennium Cohort Study. Journal of Epidemiology and Community Health 2009;63(6):474-80.
114. Polanska K, Hanke W, Sobala W. Characteristic of the smoking habit among pregnant women on the base of the test "Why am I a smoker?" [Charakterystyka nagogu palenia papierosow wsrod kobiet ciezarnych na podstawie testu Dlaczego pale?]. Przeglad Lekarski 2005;62(10):1095-8.
115. Potter A, Lumley J, Watson L. The 'new' risk factors for SIDS: is there an association with ethnic and place of birth differences in incidence in Victoria?. Early Human Development 1996;45:119-31.
116. Quinn VP, Mullen PD, ErshoffDH. Women who stop smoking spontaneously prior to prenatal care and predictors of relapse before delivery. Addictive Behaviour 1991;16(1-2):29-40.
117. Regan AK, PromoffG, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tobacco Control 2013;22(1):19-23.
118. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
119. Richmond R. You've come a long way baby: women and the tobacco epidemic. Addiction 2003;98(5):553-7.
120. Rore C, Brace V, Danielian P, Williams D. Smoking cessation in pregnancy. Expert Opinion on Drug Safety 2008;7(6):727-37.
121. Ryan P, Booth R, Coates D, Chapman A, Healy P. Experiences of Pregnancy. Pregnant Pause Campaign. Sydney: Health Commission of New South Wales, Division of Drug and Alcohol Services, 1980.
122. Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Human Development 2007;83(11):713-20.
123. Samet JM, Yoon SY. Women and the Tobacco Epidemic: Challenges for the 21st Century. Geneva: World Health Organization, 2001.
124. Schmidt S. Nicotine addiction. Journal of Addictive Nursing 2004;15(2):15.
125. Schneider S, Schutz J. Who smokes during pregnancy? A systematic literature review of population-based surveys conducted in developed countries between 1997 and 2006. European Journal of Contraception and Reproductive Health Care 2008;13(2):138-47.
126. Slemmer JE, Martin BR, Damaj MI, Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. Journal of Pharmacology & Experimental Therapeutics 2000;295(1):321-7.
127. Small R. Mothers in a New Country (MINC) [thesis]. Victoria: LaTrobe University, 2000.
128. Squires J, Twombly E, Bricker D, Potter L. ASQ-3 User's Guide for the Ages and Stages Questionnaires Third Edition. Baltimore, MD: Paul H Brookes Publishing Co, 2009.
129. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002;4(2):149-59.
130. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
131. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD002850.pub2]
132. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chemical Reviews 1968;68(2):153-207.
133. Tappin DM, Ford RP, Nelson KP, Wild CJ. Prevalence of smoking in early pregnancy by census area, measured by anonymous cotinine testing of residual antenatal blood samples. New Zealand Medical Journal 1996;109(1018):101-3.
134. Tappin DM, MacAskill S, Bauld L, Eadie D, Shipton D, Galbraith L. Smoking prevalence and smoking cessation services for pregnant women in Scotland. Substance Abuse: Treatment, Prevention, and Policy 2010;5:doi:10.1186/1747-597X-5-1.
135. The NHS Information Centre (IFF Research). Infant feeding survey 2010. Early results. Health Care and Social Care Information Centre. The National Health Service Information Centre for Health and Social Care, 2011:1-22.
136. Tong VT, Jones JR, Dietz PM, D'Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy - Pregnancy risk assessment monitoring system (PRAMS), United States, 31 sites, 2000-2005. Morbidity and Mortality Weekly Report 2009;58:1-29.
137. Troe EJ, Raat H, Jaddoe VW, Hofman A, Steegers EA, Verhulst FC, et al. Smoking during pregnancy in ethnic populations: the Generation R study. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco 2008;10(8):1373-84. [PUBMED: 18686185]
138. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007253.pub3]
139. U.S. Department of Health and Human Services. The Health Consequences of Smoking. 2004 Surgeon General's Report. U.S. Department of Health and Human Services, 2004.
140. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine & Tobacco Research 2013;15(10):1787-91.
141. Wanless D. Securing Good Health for the Whole Population. London: TSO, 2004.
142. West R, Hajek P, Stead L, Stapleton J, West R, Hajek P, et al. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.
143. World Health Organization. Report on the Global Tobacco Epidemic 2008-the mpower package. WHO (http://www.who.int/tobacco/mpower/en/index.html) (accessed 2008) 2008.
144. Grana R, Benowitz N, Glanz SA. Background paper on e-cigarettes (Electronic Nicotine Delivery Systems): WHO report. Vol. Available at: http://escholarship.org/uc/item/13p2b72n and http://www.arizonansconcernedaboutsmoking.com/201312e-cig_report.pdf, Geneva: World Health Organisation, 2013.
145. Wiemann CM, Berenson AB, San Miguel VV. Tobacco, alcohol and illicit drug use among pregnant women: age and racial/ethnic differences. Journal of Reproductive Medicine 1994;39(10):769-76.
146. Woodby LL, Windsor RA, Snyder SW, Kohler CL, Diclemente CC. Predictors of smoking cessation during pregnancy. Addiction 1999;94(2):283-92.
147. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tobacco Control 2014;23(Suppl 3):iii3-9.
148. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010078]
149. Lumley J. Advice as a strategy for reducing smoking in pregnancy. [revised 02 October 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
150. Lumley J. Behavioural strategies for reducing smoking in pregnancy. [revised 27 September 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
151. Lumley J. Counselling for reducing smoking in pregnancy. [revised 02 October 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
152. Lumley J. Feedback as a strategy for reducing smoking in pregnancy. [revised 27 September 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
153. Lumley J. Strategies for reducing smoking in pregnancy. [revised 02 October 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
154. Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001055]
155. Lumley J, Oliver S, Chamberlain C, Oakley L. Interventions for promoting smoking cessation in pregnancy. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD001055.pub2]
156. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001055.pub3]